Dr. Rose highlighted a discrepancy in how healthcare and society respond to rare events, drawing a parallel between the screening for cancers and the monitoring of vaccine side effects.
She noted that millions are screened for cancers with much lower incidence rates than some of the adverse events observed post-vaccination, questioning why similar caution is not applied to vaccine safety monitoring.
“When the headlines come out about vaccines versus COVID, they’re often downplayed in various ways, or the headlines themselves minimize what’s happening. Okay. And the issue is that, in our society and in healthcare in general, we do care about the few or the rare occurrences, right? Thus, we conduct screenings for everyone 45 years and older, encompassing hundreds of thousands or millions of people who need to be screened because we’re concerned about the 32 out of every 100,000 people who get it per year.”
“The same applies to women and cervical cancer: 7.7 females out of every 100,000 per year get cervical cancer. These are rarer, fewer events that occur. But we care about them. We don’t downplay them, and we screen these individuals, trying to prevent it from happening. That was my point.”
Dr. Rose criticized the study for not investigating a wider range of symptoms reported by vaccinated individuals, which, though less severe, significantly impact daily life. Symptoms such as chest heaviness, persistent headaches, brain fog, and new onset cardiac arrhythmias have been reported by many, yet their prevalence and connection to the vaccine remain underexplored.
“There are tens of millions of people out there who are screaming from the rooftops, saying that after they had the vaccine, they have suffered from just basic symptoms, or not that basic, but not as severe as this, but symptoms that have impaired their activities of daily living.”
“They can’t live the way they used to live on a daily basis. And those are things including chest heaviness, persistent headaches every day, brain fog, post-exertional malaise, neuropathy, weakness, new-onset cardiac arrhythmias, structural heart damage, autoimmune conditions, all these different things. I can name 100 other things, probably. Why are we not looking at those things? The things that we are looking at in this study, particularly, are things that are super rare and very serious and life-threatening.”
